info@news-matic.com

Mabwell's clinical trial application for 9MW5211 cleared by US FDA

11 May 2026 - Chinese biopharmaceutical company Mabwell (SH:688062) (HK:02493) announced on Friday that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel an...

Cookie Consent + Tracking